Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tartrazine (FD&C Yellow No. 5) is a synthetic azo dye traditionally used as a food coloring agent. In a novel medical application being evaluated by Johns Hopkins University, topical tartrazine is utilized as an optical clearing agent to induce temporary skin transparency. The mechanism involves the dye's strong light-absorption properties, which, when dissolved in the interstitial fluid of tissues, increase the refractive index of the aqueous environment to match that of lipids. This reduction in refractive index mismatch significantly minimizes light scattering, allowing for deeper and clearer optical imaging of subcutaneous structures. This effect is reversible and is being investigated for diagnostic applications in dermatology and medical imaging.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tartrazine.